Spatial association of prolyl oligopeptidase, inositol 1,4,5-triphosphate type 1 receptor, substance P and its neurokinin-1 receptor in the rat brain: An immunohistochemical colocalization study

Neuroscience

Volumn 153, Issue 4, 2008, Pages 1177-1189

  Myohanen T T ^a   Venalainen J I ^a   Garcia Horsman, J A ^b   Mannisto P T ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

long term potentiation; memory and learning; neuropeptides; protein degradation; serine endopeptidase; thalamocortical signaling

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE TYPE 1 RECEPTOR; NEUROKININ 1 RECEPTOR; PROLYL ENDOPEPTIDASE; SUBSTANCE P;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; HYDROLYSIS; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LASER MICROSCOPY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; PURKINJE CELL; SIGNAL TRANSDUCTION; STRIATE CORTEX; THALAMUS;

ANIMALS; BRAIN; CALCIUM CHANNELS; MALE; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, NEUROKININ-1; SERINE ENDOPEPTIDASES; SUBSTANCE P;

EID: 43949142408     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.02.047     Document Type: Article

References (70)

1. Abercrombie M., and Johnson M.L. Quantitative histology of Wallerian degeneration: I. Nuclear population in rabbit sciatic nerve. J Anat 80 (1946) 37-50
2. Agam G., Shamir A., Shaltiel G., and Greenberg M.L. Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs. Bipolar Disord 4 Suppl 1 (2002) 15-20
3. Agirregoitia N., Laiz-Carrion R., Varona A., Rio M.P., Mancera J.M., and Irazusta J. Distribution of peptidase activity in teleost and rat tissues. J Comp Physiol [B] 175 (2005) 433-444
4. Almeida T.A., Rojo J., Nieto P.M., Pinto F.M., Hernandez M., Martin J.D., and Candenas M.L. Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem 11 (2004) 2045-2081
5. Bellemere G., Morain P., Vaudry H., and Jegou S. Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and alpha-melanocyte-stimulating hormone breakdown in the rat brain. J Neurochem 84 (2003) 919-929
6. Bellemere G., Vaudry H., Mounien L., Boutelet I., and Jegou S. Localization of the mRNA encoding prolyl endopeptidase in the rat brain and pituitary. J Comp Neurol 471 (2004) 128-143
7. Bellemere G., Vaudry H., Morain P., and Jegou S. Effect of prolyl endopeptidase inhibition on arginine-vasopressin and thyrotrophin-releasing hormone catabolism in the rat brain. J Neuroendocrinol 17 (2005) 306-313
8. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 361 (1993) 315-325
9. Besson M.J., Graybiel A.M., and Quinn B. Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin. Neuroscience 39 (1990) 33-58
10. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
11. Cheng L., Lumb M., Polgar L., and Mudge A.W. How can the mood stabilizer VPA limit both mania and depression?. Mol Cell Neurosci 29 (2005) 155-161
12. Colonnese M.T., and Constantine-Paton M. Developmental period for N-methyl-D-aspartate (NMDA) receptor-dependent synapse elimination correlated with visuotopic map refinement. J Comp Neurol 494 (2006) 738-751
13. Daly D.J., Maskrey P., and Pennington R.J. Characterization of proline endopeptidase from skeletal muscle. Int J Biochem 17 (1985) 521-524
14. de la Vega M.T., Nunez A., and Montano J.A. Carbachol stimulates inositol phosphate formation in rat thalamus slices through muscarinic M3-receptor activation. Neurosci Lett 213 (1996) 29-32
15. Del Fiacco M., Perra M.T., Quartu M., Rosa M.D., Zucca G., and Levanti M.C. Evidence for the presence of substance P-like immunoreactivity in the human cerebellum. Brain Res 446 (1988) 173-177
16. Emson P.C., and Lindvall O. Distribution of putative neurotransmitters in the neocortex. Neuroscience 4 (1979) 1-30
17. Ferris C.D., and Snyder S.H. Inositol phosphate receptors and calcium disposition in the brain. J Neurosci 12 (1992) 1567-1574
18. Fotuhi M., Sharp A.H., Glatt C.E., Hwang P.M., von Krosigk M., Snyder S.H., and Dawson T.M. Differential localization of phosphoinositide-linked metabotropic glutamate receptor (mGluR1) and the inositol 1,4,5-trisphosphate receptor in rat brain. J Neurosci 13 (1993) 2001-2012
19. Fujii S., Sasaki H., Mikoshiba K., Kuroda Y., Yamazaki Y., Mostafa Taufiq A., and Kato H. A chemical LTP induced by co-activation of metabotropic and N-methyl-D-aspartate glutamate receptors in hippocampal CA1 neurons. Brain Res 999 (2004) 20-28
20. Fuse Y., Polk D.H., Lam R.W., Reviczky A.L., and Fisher D.A. Distribution and ontogeny of thyrotropin-releasing hormone degrading enzymes in rats. Am J Physiol 259 (1990) E787-E791
21. Gale K. Subcortical structures and pathways involved in convulsive seizure generation. J Clin Neurophysiol 9 (1992) 264-277
22. Garcia-Horsman J.A., Männistö P.T., and Venäläinen J.I. On the role of prolyl oligopeptidase in health and disease. Neuropeptides 41 (2007) 1-24
23. Goossens F., De Meester I., Vanhoof G., and Scharpe S. Distribution of prolyl oligopeptidase in human peripheral tissues and body fluids. Eur J Clin Chem Clin Biochem 34 (1996) 17-22
24. Hayashi T., and Su T.P. Regulating ankyrin dynamics: Roles of sigma-1 receptors. Proc Natl Acad Sci U S A 98 (2001) 491-496
25. Hokin L.E., and Dixon J.F. The phosphoinositide signalling system. I. Historical background II. Effects of lithium on the accumulation of second messenger inositol 1,4,5-trisphosphate in brain cortex slices. Prog Brain Res 98 (1993) 309-315
26. Huston J.P., and Hasenohrl R.U. The role of neuropeptides in learning: focus on the neurokinin substance P. Behav Brain Res 66 (1995) 117-127
27. Hutcherson L., and Roberts R.C. The immunocytochemical localization of substance P in the human striatum: a postmortem ultrastructural study. Synapse 57 (2005) 191-201
28. Inagaki S., Sakanaka M., Shiosaka S., Senba E., Takagi H., Takatsuki K., Kawai Y., Matsuzaki T., Iida H., Hara Y., and Tohyama M. Experimental and immunohistochemical studies on the cerebellar substance P of the rat: localization, postnatal ontogeny and ways of entry to the cerebellum. Neuroscience 7 (1982) 639-645
29. Jalkanen A.J., Puttonen K.A., Venäläinen J.I., Sinervä V., Mannila A., Ruotsalainen S., Jarho E.M., Wallen E.A., and Männistö P.T. Beneficial effect of prolyl oligopeptidase inhibition on spatial memory in young but not in old scopolamine-treated rats. Basic Clin Pharmacol Toxicol 100 (2007) 132-138
30. Jun K., Choi G., Yang S.G., Choi K.Y., Kim H., Chan G.C., Storm D.R., Albert C., Mayr G.W., Lee C.J., and Shin H.S. Enhanced hippocampal CA1 LTP but normal spatial learning in inositol 1,4,5-trisphosphate 3-kinase(A)-deficient mice. Learn Mem 5 (1998) 317-330
31. Kato T., Nakano T., Kojima K., Nagatsu T., and Sakakibara S. Changes in prolyl endopeptidase during maturation of rat brain and hydrolysis of substance P by the purified enzyme. J Neurochem 35 (1980) 527-535
32. Kato T., Okada M., and Nagatsu T. Distribution of post-proline cleaving enzyme in human brain and the peripheral tissues. Mol Cell Biochem 32 (1980) 117-121
33. Khodakhah K., and Armstrong C.M. Induction of long-term depression and rebound potentiation by inositol trisphosphate in cerebellar Purkinje neurons. Proc Natl Acad Sci U S A 94 (1997) 14009-14014
34. Kokko M., Kuronen I., and Kärenlampi S. Rapid production of antibodies in chicken and isolation from eggs. In: Celis J.E. (Ed). Cell biology: A laboratory handbook (1994), Elsevier Academic Press, San Diego 282-288
35. Langosch J.M., Kupferschmid S., Heinen M., Walden J., Herpfer I., Fiebich B.L., and Lieb K. Effects of substance P and its antagonist L-733060 on long term potentiation in guinea pig hippocampal slices. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 315-319
36. Lynch M.A., and Voss K.L. Presynaptic changes in long-term potentiation: elevated synaptosomal calcium concentration and basal phosphoinositide turnover in dentate gyrus. J Neurochem 56 (1991) 113-118
37. Maes M., Goossens F., Scharpe S., Meltzer H.Y., D'Hondt P., and Cosyns P. Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression. Biol Psychiatry 35 (1994) 545-552
38. Maes M., Goossens F., Scharpe S., Calabrese J., Desnyder R., and Meltzer H.Y. Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res 58 (1995) 217-225
39. Männistö P.T., Venäläinen J.I., Jalkanen A.J., and Garcia-Horsman J.A. Prolyl oligopeptidase: A potential target for the treatment of cognitive disorders. Drugs News Persp 20 (2007) 293-305
40. Mantle D., Falkous G., Ishiura S., Blanchard P.J., and Perry E.K. Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease. Clin Chim Acta 249 (1996) 129-139
41. Mares P., Pohl M., and Koryntova H. Influence of phenytoin and valproate on thalamocortical evoked potentials and their paired-pulse potentiation. Physiol Res 41 (1992) 475-478
42. McGinty J.F. Co-localization of GABA with other neuroactive substances in the basal ganglia. Prog Brain Res 160 (2007) 273-284
43. Miller J.W., and Ferrendelli J.A. The central medial nucleus: thalamic site of seizure regulation. Brain Res 508 (1990) 297-300
44. Miller J.W., and Ferrendelli J.A. Characterization of GABAergic seizure regulation in the midline thalamus. Neuropharmacology 29 (1990) 649-655
45. Morain P., Lestage P., De Nanteuil G., Jochemsen R., Robin J.L., Guez D., and Boyer P.A. S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies. CNS Drug Rev 8 (2002) 31-52
46. Myöhänen T.T., Venäläinen J.I., Tupala E., Garcia-Horsman J.A., Miettinen R., and Männistö P.T. Distribution of immunoreactive prolyl oligopeptidase in human and rat brain. Neurochem Res 32 (2007) 1365-1374
47. Myöhänen T.T., Venäläinen J.I., Garcia-Horsman J.A., Piltonen M., and Männistö P.T. Cellular and subcellular distribution of rat brain prolyl oligopeptidase and its association with specific neuronal neurotransmitters. J Comp Neurol 507 (2007) 1694-1708
48. Nakaya Y., Kaneko T., Shigemoto R., Nakanishi S., and Mizuno N. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J Comp Neurol 347 (1994) 249-274
49. Nowack W.J., Johnson R.N., Englander R.N., and Hanna G.R. Effects of valproate and ethosuximide on thalamocortical excitability. Neurology 29 (1979) 96-99
50. Paxinos G., and Watson C.G. The rat brain in stereotaxic coordinates. 2nd ed. (1997), Elsevier Academic Press, San Diego
51. Paxinos G. The rat nervous system. 3rd ed. (2004), Elsevier Academic Press, San Diego
52. Piggins H.D., Samuels R.E., Coogan A.N., and Cutler D.J. Distribution of substance P and neurokinin-1 receptor immunoreactivity in the suprachiasmatic nuclei and intergeniculate leaflet of hamster, mouse, and rat. J Comp Neurol 438 (2001) 50-65
53. Polgar L. Prolyl oligopeptidases. Methods Enzymol 244 (1994) 188-200
54. Rawlings N.D., Polgar L., and Barrett A.J. A new family of serine-type peptidases related to prolyl oligopeptidase. Biochem J 279 Pt 3 (1991) 907-908
55. Schneider J.S., Giardiniere M., and Morain P. Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys. Neuropsychopharmacology 26 (2002) 176-182
56. Schulz I., Gerhartz B., Neubauer A., Holloschi A., Heiser U., Hafner M., and Demuth H.U. Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. Eur J Biochem 269 (2002) 5813-5820
57. Sharp A.H., Dawson T.M., Ross C.A., Fotuhi M., Mourey R.J., and Snyder S.H. Inositol 1,4,5-trisphosphate receptors: immunohistochemical localization to discrete areas of rat central nervous system. Neuroscience 53 (1993) 927-942
58. Taufiq A.M., Fujii S., Yamazaki Y., Sasaki H., Kaneko K., Li J., Kato H., and Mikoshiba K. Involvement of IP3 receptors in LTP and LTD induction in guinea pig hippocampal CA1 neurons. Learn Mem 12 (2005) 594-600
59. Toide K., Iwamoto Y., Fujiwara T., and Abe H. JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer. J Pharmacol Exp Ther 274 (1995) 1370-1378
60. Toide K., Okamiya K., Iwamoto Y., and Kato T. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on prolyl endopeptidase activity and substance P- and arginine-vasopressin-like immunoreactivity in the brains of aged rats. J Neurochem 65 (1995) 234-240
61. Toide K., Fujiwara T., Iwamoto Y., Shinoda M., Okamiya K., and Kato T. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 353 (1996) 355-362
62. Toide K., Shinoda M., Fujiwara T., and Iwamoto Y. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats. Pharmacol Biochem Behav 56 (1997) 427-434
63. Venäläinen J.I., Garcia-Horsman J.A., Forsberg M.M., Jalkanen A., Wallen E.A., Jarho E.M., Christiaans J.A., Gynther J., and Männistö P.T. Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors. Biochem Pharmacol 71 (2006) 683-692
64. Venäläinen J.I., Juvonen R.O., Forsberg M.M., Garcia-Horsman A., Poso A., Wallen E.A., Gynther J., and Männistö P.T. Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819. Biochem Pharmacol 64 (2002) 463-471
65. Venäläinen J.I., Juvonen R.O., and Männistö P.T. Evolutionary relationships of the prolyl oligopeptidase family enzymes. Eur J Biochem 271 (2004) 2705-2715
66. Vermassen E., Parys J.B., and Mauger J.P. Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol Cell 96 (2004) 3-17
67. Williams R.S., and Harwood A.J. Lithium therapy and signal transduction. Trends Pharmacol Sci 21 (2000) 61-64
68. Williams R.S., Cheng L., Mudge A.W., and Harwood A.J. A common mechanism of action for three mood-stabilizing drugs. Nature 417 (2002) 292-295
69. Williams R.S. Pharmacogenetics in model systems: Defining a common mechanism of action for mood stabilisers. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 1029-1037
70. Zhang Y.F., Gibbs III J.W., and Coulter D.A. Anticonvulsant drug effects on spontaneous thalamocortical rhythms in vitro: valproic acid, clonazepam, and alpha-methyl-alpha-phenylsuccinimide. Epilepsy Res 23 (1996) 37-53